Samir M. Deshpande - 15 Dec 2024 Form 4 Insider Report for HUMANA INC (HUM)

Role
Chief Information Officer
Signature
Samir M. Deshpande
Issuer symbol
HUM
Transactions as of
15 Dec 2024
Net transactions value
-$144,803
Form type
4
Filing time
17 Dec 2024, 13:43:34 UTC
Previous filing
23 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUM Humana Common Tax liability $60,040 -221 -1.6% $271.68 13,639 15 Dec 2024 Direct F9
transaction HUM Humana Common Options Exercise $0 +353 +2.6% $0.000000 13,992 15 Dec 2024 Direct
transaction HUM Humana Common Tax liability $43,468 -160 -1.1% $271.68 13,832 15 Dec 2024 Direct F9
transaction HUM Humana Common Options Exercise $0 +335 +2.4% $0.000000 14,167 15 Dec 2024 Direct
transaction HUM Humana Common Tax liability $41,295 -152 -1.1% $271.68 14,015 15 Dec 2024 Direct F9, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Options Exercise $0 -353 -100% $0.000000 0 15 Dec 2024 Humana Common 353 Direct F6, F7
transaction HUM Restricted Stock Units Options Exercise $0 -335 -50% $0.000000 335 15 Dec 2024 Humana Common 335 Direct F6, F8
holding HUM Options 5,730 15 Dec 2024 Humana Common 5,730 $350.79 Direct F1
holding HUM Options 4,327 15 Dec 2024 Humana Common 4,327 $376.61 Direct F2
holding HUM Options 3,836 15 Dec 2024 Humana Common 3,836 $425.06 Direct F3
holding HUM Options 3,878 15 Dec 2024 Humana Common 3,878 $510.24 Direct F4
holding HUM Options 5,652 15 Dec 2024 Humana Common 5,652 $367.21 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
F2 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
F3 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
F4 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F5 Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
F6 Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F7 Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F8 Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F9 Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/24.
F10 Includes 976 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.